Dear
Colleague:
On behalf of
the Scientific Committee it is our pleasure to announce the 2nd
Call for Abstracts for the 8th HIC-RPC Bioseparation Conference
being held March 3-7, 2013 at the Westin
Savannah Harbor Resort in Savannah, Georgia, USA.This conference
series, which alternates between Europe and the US, provides a unique
forum for in-depth discussions on downstream bioprocessing related
to two powerful modes of chromatography: Hydrophobic Interaction
and Reversed Phase as well as other novel modes of separations that
exploit hydrophobic interactions such as multimodal systems. Two
of the highlights of this conference will be keynote talks by Prof.
Shekhar Garde (RPI) and Prof. Milton Hearn (Monash) on the paradigm
shift that is reshaping our fundamental understanding of how water
affects hydrophobic Interactions in protein systems
2nd
Call for abstracts
Abstracts on
the topics listed below are now being accepted. Oral and poster
presentations are welcome. Each abstract should be no more than
150 words. The submission deadline is October 12, 2012.
To submit your
abstract, please complete this form.
Abstract
topics:
- Industrial
Case Studies in HIC, RPC and Multimodal Purifications
- Fundamentals
of HIC/RPC/Multimodal Chromatography
- Novel Stationary
Phases
- New Engineering
Approaches for Downstream Bioprocessing
- Protein
Structure, Interactions and Stability
- Antibody
Conjugates: Challenges for Bioprocessing
- High Throughput
Methodologies
- Biosimilars
- Quality
by Design/Regulatory Aspects
For additional
conference details, please see: www.hic-rpc.org.
We look forward
to your participation in the conference.
Best regards,

Steven M. Cramer, Ph.D.
Scientific Committee Chair
8th HIC-RPC Bioseparation Conference
|
Scientific
Committee Chair
Prof.
Steven M. Cramer
Rensselaer Polytechnic Institute
Scientific Committee
Tim
Breece
Xoma Ltd.
Jie
Chen
DYAX CORP
Klaus
Graumann
Sandoz GmbH
Professor
Milton T. W. Hearn
Monash University
Prof.
Alois Jungbauer
University of Natural Resources and Applied Life Sciences
Wolfgang
Kuhne
Roche Diagnostics GmbH
Egbert
Müller
Tosoh Bioscience GmbH
Arne
Staby
Novo Nordisk A/S
Rick
St. John
Genentech Inc |
|